Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
Synthesis and Analgesic Activity of Cridanimod–Monoterpene Conjugates. / Anikev, Danil D.; Filippova, Anastasia Yu; Yarovaya, Olga I. и др.
в: Scientia Pharmaceutica, Том 94, № 3, 63, 31.07.2026.Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
}
TY - JOUR
T1 - Synthesis and Analgesic Activity of Cridanimod–Monoterpene Conjugates
AU - Anikev, Danil D.
AU - Filippova, Anastasia Yu
AU - Yarovaya, Olga I.
AU - Tishchenko, Serafim A.
AU - Pavlova, Alla V.
AU - Sonina, Alina A.
AU - Kovaleva, Kseniya S.
AU - Khvostov, Mikhail V.
AU - Tolstikova, Tatyana G.
AU - Petrov, Andrey Yu.
AU - Salakhutdinov, Nariman F.
N1 - Anikev, D.D.; Filippova, A.Y.; Yarovaya, O.I.; Tishchenko, S.A.; Pavlova, A.V.; Sonina, A.A.; Kovaleva, K.S.; Khvostov, M.V.; Tolstikova, T.G.; Petrov, A.Y.; et al. Synthesis and Analgesic Activity of Cridanimod–Monoterpene Conjugates. Sci. Pharm. 2026, 94, 63. https://doi.org/10.3390/scipharm94030063 This work was financially supported by the Russian Science Foundation and the Government of the Novosibirsk region (Project № 26-23-20046).
PY - 2026/7/31
Y1 - 2026/7/31
N2 - Cridanimod (acridoneacetic acid), the active ingredient of the immunomodulatory drug Cycloferon®, has a well-characterized antiviral profile, but an unexplored analgesic potential. Bornane monoterpenes, notably (+)-camphor and (−)-fenchone, are established scaffolds for analgesic drug design. We therefore synthesized thirteen cridanimod–monoterpene conjugates—seven amides, three acylhydrazones, and three esters—by EDCI/DMAP-mediated coupling or CDI/DBU-promoted esterification, and evaluated them in mice at an oral dose of 10.0 mg/kg in the acetic acid writhing and hot plate tests, with diclofenac sodium (10.0 mg/kg) as the reference. Acridoneacetic acid and Cycloferon® were themselves inactive in both assays. By contrast, six of the thirteen conjugates were significantly active (p < 0.05) in at least one test, with distinct leads in each: amide 19 matched diclofenac in the writhing test (−63.7% vs. −64.4%), whereas acylhydrazone 23 exceeded diclofenac in the hot plate test (+43.9% vs. +25.7%). The divergent profiles suggest that different structural subclasses engage peripheral and central antinociceptive mechanisms. Conjugation thus converts an analgesically inactive immunomodulator into a substance yielding analgesics that match or exceed a standard NSAID at the same oral dose, providing a promising starting point for the development of new pain-relieving agents.
AB - Cridanimod (acridoneacetic acid), the active ingredient of the immunomodulatory drug Cycloferon®, has a well-characterized antiviral profile, but an unexplored analgesic potential. Bornane monoterpenes, notably (+)-camphor and (−)-fenchone, are established scaffolds for analgesic drug design. We therefore synthesized thirteen cridanimod–monoterpene conjugates—seven amides, three acylhydrazones, and three esters—by EDCI/DMAP-mediated coupling or CDI/DBU-promoted esterification, and evaluated them in mice at an oral dose of 10.0 mg/kg in the acetic acid writhing and hot plate tests, with diclofenac sodium (10.0 mg/kg) as the reference. Acridoneacetic acid and Cycloferon® were themselves inactive in both assays. By contrast, six of the thirteen conjugates were significantly active (p < 0.05) in at least one test, with distinct leads in each: amide 19 matched diclofenac in the writhing test (−63.7% vs. −64.4%), whereas acylhydrazone 23 exceeded diclofenac in the hot plate test (+43.9% vs. +25.7%). The divergent profiles suggest that different structural subclasses engage peripheral and central antinociceptive mechanisms. Conjugation thus converts an analgesically inactive immunomodulator into a substance yielding analgesics that match or exceed a standard NSAID at the same oral dose, providing a promising starting point for the development of new pain-relieving agents.
KW - Cycloferon®
KW - acridoneacetic acid
KW - analgesic activity
KW - camphor
KW - cridanimod
KW - fenchone
KW - hot plate test
KW - monoterpenes
KW - structure–activity relationship
KW - writhing test
KW - криданимод
KW - акридонуксусная кислота
KW - Циклоферон®
KW - монотерпены
KW - камфора
KW - фенхон
KW - анальгетическая активность
KW - тест «корчи»
KW - тест «горячая пластина»
KW - взаимосвязь «структура–активность»
UR - https://www.mendeley.com/catalogue/3d872590-4f78-30a1-ad26-eb75db9f5dda/
UR - https://www.scopus.com/pages/publications/105052575312
U2 - 10.3390/scipharm94030063
DO - 10.3390/scipharm94030063
M3 - Article
VL - 94
JO - Scientia Pharmaceutica
JF - Scientia Pharmaceutica
SN - 2218-0532
IS - 3
M1 - 63
ER -
ID: 85310481